254 related articles for article (PubMed ID: 33379241)
1. Long Non-Coding RNAs in Diffuse Large B-Cell Lymphoma.
Karstensen KT; Schein A; Petri A; Bøgsted M; Dybkær K; Uchida S; Kauppinen S
Noncoding RNA; 2020 Dec; 7(1):. PubMed ID: 33379241
[TBL] [Abstract][Full Text] [Related]
2. Non-Coding RNAs in Diffuse Large B-Cell Lymphoma.
Shi Y; Ding D; Qu R; Tang Y; Hao S
Onco Targets Ther; 2020; 13():12097-12112. PubMed ID: 33262609
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma.
Verma A; Jiang Y; Du W; Fairchild L; Melnick A; Elemento O
Genome Med; 2015 Nov; 7():110. PubMed ID: 26521025
[TBL] [Abstract][Full Text] [Related]
4. [Research on Ralation of Long Non-coding RNA with Diffuse Large B-cell Lymphomas -Review].
Wu YY; Xing YR; Yu DN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):609-614. PubMed ID: 29665941
[TBL] [Abstract][Full Text] [Related]
5. Predictive analysis of long non-coding RNA expression profiles in diffuse large B-cell lymphoma.
Zhu D; Fang C; Li X; Geng Y; Li R; Wu C; Jiang J; Wu C
Oncotarget; 2017 Apr; 8(14):23228-23236. PubMed ID: 28423571
[TBL] [Abstract][Full Text] [Related]
6. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA as a novel biomarker and therapeutic target in aggressive B-cell non-Hodgkin lymphoma: A systematic review.
Khanmohammadi S; Fallahtafti P
J Cell Mol Med; 2023 Jul; 27(14):1928-1946. PubMed ID: 37246627
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization.
Cascione L; Giudice L; Ferraresso S; Marconato L; Giannuzzi D; Napoli S; Bertoni F; Giugno R; Aresu L
Noncoding RNA; 2019 Sep; 5(3):. PubMed ID: 31546795
[TBL] [Abstract][Full Text] [Related]
9. A Pooled Analysis of The Clinical Utilities of Long Non-Coding RNA Based Molecular Signature for Diffuse Large B Cell Lymphoma.
Xu P; Chen X; Su P
Clin Lab; 2017 Nov; 63(11):1831-1840. PubMed ID: 29226652
[TBL] [Abstract][Full Text] [Related]
10. Pathologically complete remission to combination of invariant NK T cells and anti-CD20 antibody in a refractory HIV+ diffuse large B-cell lymphoma patient.
Wang J; Zhang R; Ding X; Jin Y; Qin R; Xia B; Liao Q; Hu H; Song W; Wang Z; Zhang X; Xu J
Immunotherapy; 2022 Jun; 14(8):599-607. PubMed ID: 35443802
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
[TBL] [Abstract][Full Text] [Related]
12. Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway.
Wang Y; Zhang M; Xu H; Wang Y; Li Z; Chang Y; Wang X; Fu X; Zhou Z; Yang S; Wang B; Shang Y
Oncotarget; 2017 Sep; 8(42):72182-72196. PubMed ID: 29069778
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNAs in Diffuse Large B-Cell Lymphoma: Current Advances and Perspectives.
Huang X; Qian W; Ye X
Onco Targets Ther; 2020; 13():4295-4303. PubMed ID: 32547063
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA TRIM52-AS1 sponges microRNA-577 to facilitate diffuse large B cell lymphoma progression via increasing TRIM52 expression.
Zhao F; Li S; Liu J; Wang J; Yang B
Hum Cell; 2022 Jul; 35(4):1234-1247. PubMed ID: 35676608
[TBL] [Abstract][Full Text] [Related]
15. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.
Camicia R; Winkler HC; Hassa PO
Mol Cancer; 2015 Dec; 14():207. PubMed ID: 26654227
[TBL] [Abstract][Full Text] [Related]
16. Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma.
Gao HY; Wu B; Yan W; Gong ZM; Sun Q; Wang HH; Yang W
Oncol Rep; 2017 Sep; 38(3):1363-1372. PubMed ID: 28713985
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of differentially expressed profiles of lncRNAs and mRNAs reveals ceRNA networks in the transformation of diffuse large B-cell lymphoma.
Tian L; He Y; Zhang H; Wu Z; Li D; Zheng C
Oncol Lett; 2018 Jul; 16(1):882-890. PubMed ID: 29963159
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs expression levels in diffuse large B-cell lymphoma: An in silico analysis.
Dousti F; Shahrisa A; Ansari H; Hajjari M; Tahmasebi Birgani Y; Mohammadiasl J; Tahmasebi Birgani M
Pathol Res Pract; 2018 Sep; 214(9):1462-1466. PubMed ID: 30104077
[TBL] [Abstract][Full Text] [Related]
19. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
Meng H; Zhao B; Wang Y
Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NORAD Mediates the Proliferation and Apoptosis of Diffuse Large-B-Cell Lymphoma via Regulation of miR-345-3p/TRAF6 Axis.
Li Y; Lv Y; Wang J; Zhu X; Chen J; Zhang W; Wang C; Jiang L
Arch Med Res; 2022 Apr; 53(3):271-279. PubMed ID: 35164979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
